Among the TFs in the oncogenic pathways, the expression levels of LEF1 and TEAD4 were found to be significantly altered in ESCC samples and they participated in the abnormally activated oncogenic pathways such as WNT and Hippo signaling. The gene discussed is TEAD4; the disease is esophageal squamous cell carcinoma.